Results 111 to 120 of about 558,945 (252)

Strategies for treating acute pain in patients with opioid dependence: a scoping review protocol. [PDF]

BMJ Open
Levine S, Andrews M, Saracco B, Salzman M.   +3 more
europepmc   +1 more source

An investigation of the central mechanisms of morphine-and narcotic antagonist-induced hypothermia in the naive and dependent rat /

, 1976
Eugene R. Baizman
openalex   +1 more source

Prevalence of AAS-Positive Samples at Drug Abuse Laboratory Sweden Between 2014 and 2023 and Sub-Study of Dual Use of AAS and Narcotics. [PDF]

Drug Test Anal
Bohlin KP, Villén T, Hopcraft O, Pohanka A, Ekström L.   +4 more
europepmc   +1 more source

Cardiovascular manifestations in mast cell activation disease: key insights for cardiologists and angiologists. [PDF]

Front Cardiovasc Med
Taumann W, Molderings GJ.
europepmc   +1 more source

The role of central versus peripheral opioid receptors in fentanyl-induced brain hypoxia. [PDF]

J Neurophysiol
Kiyatkin EA, Limiac FG, Noya MR, Gomez JL, Michaelides M, Shaham Y.   +5 more
europepmc   +1 more source

Identifying Optimal Thresholds for Early Opioid Use Frequency in Predicting Buprenorphine Outcomes. [PDF]

J Clin Psychiatry
Votaw VR, Bailey AJ, Weiss RD, McHugh RK.   +3 more
europepmc   +1 more source

DFT study of species derived from the narcotic antagonist naloxone

, 2020
M. Marquez, Silvia Antonia Brandán, S Brandn, R Rudyk, S Brandn, D Romani, S Brandn, M Iramain, A Ledesma, S Brandn, S Brandn, R Rudyk, M Checa, K Guzzetti, M Iramain, S Brandn, R Rudyk, M Checa, C Cataln, S Brandn, Structural, M Manzur, S Brandn, S Brandn, M Iramain, L Davies, S Brandn, Ftir, J Kausteklis, V Aleksa, M Iramain, S Brandn, M Iramain, L Davies, S Brandn, J Kausteklis, V Aleksa, M Iramain, S Brandn, M Iramain, L Davies, S Brandn, M Iramain, A Ledesma, S Brandn, M Iramain, S Brandn, M Mrquez, M Iramain, S Brandn, I Karle, D Wermeling, C Pert, G Pasternak, S Snyder, C Pert, S Snyder, C Lee, W Yang, R Parr, A Becke, S Miertus, E Scrocco, J Tomasi, J Tomasi, J Persico, A Marenich, C Cramer, D Truhlar, P Pulay, G Fogarasi, G Pongor, J Boggs, A Vargha, G Rauhut, P Pulay, T Sundius, R Paar, R Pearson, M Minteguiaga, E Dellacassa, M Iramain, C Cataln, S Brandn, B Brandn, S Issaoui, N Roisnel, T Marouani, H Synthesis, S Gatfaoui, N Issaoui, S Brandn, T Roisnel, H Marouani, M Minteguiaga, E Dellacassa, M Iramain, C Cataln, S Brandn, Ft-Ir   +99 more
openalex   +1 more source

Effectiveness, acceptability, and feasibility of naloxone in carceral settings: a scoping review. [PDF]

Harm Reduct J
Ravichandran N, Cullen W, Van Hout MC, Smyth J, Crowley D.   +4 more
europepmc   +1 more source

Naldemedine for the Prevention of Recurrent Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled Trial. [PDF]

United European Gastroenterol J
Cook ME, Knoph CS, Davidsen L, Frøkjær JB, Bruun NH, Novovic S, Hadi A, Jørgensen MT, Mortensen MB, Schaffalitzky O, Nielsen LBJ, Berner-Hansen M, Drewes AM, Olesen SS.   +13 more
europepmc   +1 more source

Therapeutic Potential of Naltrexone in the Niche of Psychopharmacology. [PDF]

Psychopharmacol Bull
Naguy A, Alamiri B.
europepmc   +1 more source